← COLGATE PALMOLIVE CO

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $2.4b
$2.0b -17.08%
$2.4b +18.58%
$2.4b -1.38%
$2.7b +13.86%
$2.2b -19.63%
$1.8b -17.59%
$2.3b +28.85%
$2.9b +25.61%
$2.1b -26.20%
—
Net Income (Loss) Attributable to Noncontrolling Interest $145.0m $150.0m $158.0m $160.0m $165.0m $172.0m $182.0m $155.0m $160.0m $129.0m —
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $2.6b $2.2b $2.6b $2.5b $2.9b $2.3b $2.0b $2.5b $3.0b $2.3b —
Amortization of Intangible Assets $33.0m $35.0m $59.0m $62.0m $88.0m $89.0m $80.0m $72.0m $75.0m $78.0m —
Depreciation, Depletion and Amortization $443.0m $475.0m $511.0m $519.0m $539.0m $556.0m $545.0m $567.0m $605.0m $630.0m $597.0m
Deferred Income Tax Expense (Benefit) $71.0m $108.0m $53.0m $19.0m ($143.0m) ($37.0m) ($163.0m) ($135.0m) ($33.0m) ($156.0m) ($2.0m)
Deferred Other Tax Expense (Benefit) — — — — — — — — — ($49.0m) —
Deferred income taxes $56.0m $108.0m $27.0m $17.0m ($120.0m) ($132.0m) ($78.0m) ($98.0m) ($77.0m) ($109.0m) ($2.0m)
Share-based Payment Arrangement, Expense $123.0m $127.0m $109.0m $100.0m $107.0m $135.0m $125.0m $122.0m $135.0m $155.0m $147.0m
Share-based Payment Arrangement, Noncash Expense $123.0m $127.0m $109.0m $100.0m $107.0m $135.0m $125.0m $122.0m $135.0m $155.0m $147.0m
Stock-based compensation expense $123.0m $127.0m $109.0m $100.0m $107.0m $135.0m $125.0m $122.0m $135.0m $155.0m $147.0m
Goodwill and Intangible Asset Impairment — — — — $0 $571.0m $721.0m $0 $0 $919.0m —
Goodwill and intangible assets impairment charges — — — — $0 $571.0m $721.0m $0 $0 $919.0m —
Goodwill, Impairment Loss — — — — — — $332.0m $0 — $582.0m $919.0m
Income (Loss) from Equity Method Investments $10.0m $11.0m $10.0m $9.0m $12.0m $12.0m $12.0m $17.0m $22.0m $20.0m —
Changes in operating assets and liabilities:
Receivables ($17.0m) ($15.0m) ($79.0m) $19.0m $138.0m ($84.0m) ($227.0m) ($37.0m) ($56.0m) ($16.0m) $101.0m
Increase (Decrease) in Inventories $4.0m $8.0m $58.0m $77.0m $251.0m $72.0m $333.0m ($194.0m) $100.0m ($109.0m) ($80.0m)
Inventories ($4.0m) ($8.0m) ($58.0m) ($77.0m) ($251.0m) ($72.0m) ($333.0m) $194.0m ($100.0m) $109.0m ($80.0m)
Accounts payable and other working capital — — — — — — — $309.0m $516.0m $251.0m —
Other Operating Income (Expense), Net ($37.0m) ($194.0m) ($148.0m) ($196.0m) ($113.0m) ($65.0m) ($69.0m) ($191.0m) ($164.0m) ($123.0m) —
Net Cash Provided by (Used in) Operating Activities $3.1b
$3.1b -2.77%
$3.1b +0.07%
$3.1b +2.52%
$3.7b +18.70%
$3.3b -10.59%
$2.6b -23.13%
$3.7b +46.52%
$4.1b +9.67%
$4.2b +2.22%
$3.9b -6.62%
Cash flows from investing activities:
Gain (Loss) on Disposition of Property Plant Equipment $97.0m $0 $0 — — — — — — — —
Payments to Acquire Property, Plant, and Equipment $593.0m $553.0m $436.0m $335.0m $409.0m $567.0m $696.0m ($705.0m) ($561.0m) ($564.0m) ($550.0m)
Proceeds from sale of marketable securities and investments $378.0m $391.0m $156.0m $131.0m $124.0m $141.0m $322.0m $502.0m $564.0m $752.0m —
Purchases of marketable securities and investments ($336.0m) ($347.0m) ($169.0m) ($184.0m) ($143.0m) ($141.0m) ($470.0m) ($506.0m) ($574.0m) ($698.0m) —
Payment for acquisitions, net of cash acquired ($5.0m) $0 ($728.0m) ($1.7b) ($353.0m) $0 ($809.0m) $0 $0 ($293.0m) —
Payments to Acquire Businesses, Net of Cash Acquired $5.0m $0 $728.0m $1.7b $353.0m $0 $809.0m $0 $0 $293.0m ($293.0m)
Other investing activities ($3.0m) ($6.0m) $6.0m ($1.0m) $3.0m ($25.0m) $5.0m ($33.0m) $37.0m ($14.0m) —
Payments for (Proceeds from) Other Investing Activities $3.0m $6.0m ($6.0m) $1.0m ($3.0m) $25.0m ($5.0m) $33.0m ($37.0m) $14.0m —
Net Cash Provided by (Used in) Investing Activities ($499.0m) ($471.0m) ($1.2b) ($2.1b) ($779.0m) ($592.0m) ($1.6b) ($742.0m) ($534.0m) ($817.0m) ($790.0m)
Cash flows from financing activities:
Gain (Loss) on Extinguishment of Debt — — — — ($23.0m) ($75.0m) $0 $0 — — —
Principal payments on debt ($7.3b) ($4.8b) ($7.4b) ($6.6b) ($1.1b) ($703.0m) ($406.0m) ($903.0m) ($503.0m) ($655.0m) —
Proceeds from issuance of debt $7.4b $4.8b $7.2b $8.1b $0 $699.0m $1.5b $1.5b $2.0m $1.2b $497.0m
Short-term borrowing (repayment) less than 90 days, net — — — $296.0m $488.0m ($171.0m) $540.0m ($906.0m) $93.0m ($989.0m) —
Payments for Repurchase of Common Stock $1.3b $1.4b $1.2b $1.2b $1.5b $1.3b $1.3b $1.1b $1.7b $1.2b —
Dividends Payable — — — — — — — — $408.0m $418.0m —
Dividends paid ($2k) ($2k) ($2k) ($2k) ($2k) ($2k) ($2k) ($2k) ($2k) ($2k) ($1.8b)
Other financing activities — — — $15.0m $33.0m ($24.0m) ($18.0m) $18.0m ($91.0m) $132.0m —
Net Cash Provided by (Used in) Financing Activities ($2.2b)
($2.5b) -9.72%
($2.7b) -9.35%
($870.0m) +67.53%
($2.9b) -235.52%
($2.8b) +4.97%
($952.0m) +65.68%
($2.8b) -193.38%
($3.4b) -21.34%
($3.3b) +3.92%
($3.0b) +6.33%
Net increase (decrease) in Cash and cash equivalents $345.0m $220.0m ($809.0m) $157.0m $5.0m ($56.0m) ($57.0m) $191.0m $130.0m $192.0m —
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($64.0m) $87.0m ($16.0m) $157.0m $5.0m ($56.0m) ($57.0m) $191.0m $130.0m $192.0m $1.2b
Cash and cash equivalents at beginning of year $970.0m $1.3b $1.5b $883.0m $888.0m $832.0m $775.0m $966.0m $1.1b $1.3b $1.1b
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — — — $883.0m $888.0m $832.0m $775.0m $966.0m $1.1b $1.3b $1.2b
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($64.0m) $87.0m ($16.0m) ($7.0m) ($16.0m) ($15.0m) ($60.0m) ($19.0m) ($54.0m) $67.0m $25.0m
Effect of exchange rate changes on Cash and cash equivalents ($64.0m) $87.0m ($16.0m) ($7.0m) ($16.0m) ($15.0m) ($60.0m) ($19.0m) ($54.0m) $67.0m $25.0m
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Additional Financial Items
ERISA litigation matter — — — — — $0 $0 $267.0m $0 $65.0m —
Gain (Loss) on Disposition of Business $0 $0 — — — — — — — — —
Gain (Loss) on Sale of Properties — — — — — — $47.0m $0 $0 — —
Goodwill $2.1b $2.2b $2.5b $3.5b $3.8b $3.3b $3.4b $3.4b $3.3b $3.1b $919.0m
Income Tax Expense (Benefit) $1.2b $1.3b $906.0m $774.0m $787.0m $749.0m $693.0m $937.0m $907.0m $798.0m —
Income Taxes Paid, Net $932.0m $1.0b $847.0m $803.0m $845.0m $890.0m $945.0m $937.0m $933.0m $913.0m —
Interest Expense Nonoperating — — — — — — — — $292.0m $267.0m —
Interest Paid, Excluding Capitalized Interest, Operating Activities $162.0m $150.0m $194.0m $185.0m $188.0m $194.0m $151.0m $280.0m $302.0m $270.0m —
Investment Income, Interest $50.0m $51.0m $50.0m $47.0m — — — — $67.0m $75.0m —
Net cash provided by operations $3.1b $3.1b $3.1b $3.1b $3.7b $3.3b $2.6b $3.7b $4.1b $4.2b —
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax $3.0m — — — — — — — — — —
Other non-current assets — — — — — — — $53.0m $28.0m $35.0m —
Other non-current liabilities — — — — — — — ($64.0m) ($44.0m) ($95.0m) —
Proceeds from Stock Options Exercised $386.0m $507.0m $329.0m $498.0m $874.0m $424.0m $418.0m $380.0m $638.0m $101.0m —
Proceeds from exercise of stock options $446.0m $507.0m $329.0m $498.0m $874.0m $424.0m $418.0m $380.0m $638.0m $101.0m —
Purchases of treasury shares ($1.3b) ($1.4b) ($1.2b) ($1.2b) ($1.5b) ($1.3b) ($1.3b) ($1.1b) ($1.7b) ($1.2b) —
Restructuring Costs — — — — — — — $24.0m $59.0m $7.0m —
Restructuring and termination benefits, net of cash ($9.0m) $91.0m ($7.0m) $18.0m ($71.0m) ($21.0m) $49.0m ($23.0m) $51.0m ($7.0m) —
Supplemental disclosure of cash flow information:

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.